Arax Advisory Partners’s Insmed INSM Stock Holding History

Arax Advisory Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$80.8K	Buy	758 +606	+399%	+$73.4K	﹤0.01%	2885
2026 Q1	$24.9K	Sell	152 -215	-59%	-$33.1K	﹤0.01%	1998
2025 Q4	$63.9K	Sell	367 -422	-53%	-$77K	﹤0.01%	1496
2025 Q3	$114K	Buy	789 +683	+644%	+$83.7K	﹤0.01%	1492
2025 Q2	$12K	Buy	106 +80	+308%	+$6.12K	﹤0.01%	1886
2025 Q1	$1.98K	Buy	26 +13	+100%	+$994	﹤0.01%	2072
2024 Q4	$898	Sell	13 -14	-52%	-$1.01K	﹤0.01%	2199
2024 Q3	$1.97K	Buy	27 +9	+50%	+$664	﹤0.01%	2071
2024 Q2	$1.21K	Sell	18 -7	-28%	-$271	﹤0.01%	2115
2024 Q1	$679	Hold	25	–	–	﹤0.01%	1208
2023 Q4	$775	Hold	25	–	–	﹤0.01%	1167
2023 Q3	$631	Hold	25	–	–	﹤0.01%	1213
2023 Q2	$528	Buy	25 +1	+4%	+$19	﹤0.01%	1205
2023 Q1	$409	Hold	24	–	–	﹤0.01%	1214
2022 Q4	$480	Buy	+24	New	+$464	﹤0.01%	1186

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Arax Advisory Partners's INSM Position: Q2 2026 in Review

Arax Advisory Partners increased its Insmed (INSM) stake by 399% in Q2 2026, buying an estimated $73.4K and bringing the position to 758 shares worth $80.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2885.

Arax Advisory Partners first reported a position in INSM in Q4 2022 and has held it in 15 quarters since. The position peaked at $114K in Q3 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Arax Advisory Partners held 758 shares of Insmed worth $80.8K as of Q2 2026.
Arax Advisory Partners bought 606 Insmed shares in Q2 2026, an estimated $73.4K.
Insmed made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2885 holding.
Arax Advisory Partners first reported a position in Insmed in Q4 2022 and has held it in 15 quarters since.
Arax Advisory Partners's Insmed position peaked at $114K in Q3 2025.
665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.